Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth.

Chen T, Xiong J, Yang C, Shan L, Tan G, Yu L, Tan Y.

Cancer Gene Ther. 2014 Mar;21(3):133-8. doi: 10.1038/cgt.2014.8. Epub 2014 Feb 28.


Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma.

Chen H, Yang C, Yu L, Xie L, Hu J, Zeng L, Tan Y.

J Gene Med. 2012 Apr;14(4):231-40. doi: 10.1002/jgm.2614.


Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.

Yang C, Chen H, Yu L, Shan L, Xie L, Hu J, Chen T, Tan Y.

Cancer Gene Ther. 2013 Feb;20(2):117-24. doi: 10.1038/cgt.2012.94. Epub 2013 Jan 11.


Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.

Wei JC, Meng FD, Qu K, Wang ZX, Wu QF, Zhang LQ, Pang Q, Liu C.

Acta Pharmacol Sin. 2015 Feb;36(2):241-51. doi: 10.1038/aps.2014.122. Epub 2015 Jan 5.


Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.

Wu QF, Liu C, Tai MH, Liu D, Lei L, Wang RT, Tian M, Lü Y.

Acta Pharmacol Sin. 2010 Mar;31(3):361-6. doi: 10.1038/aps.2010.4. Epub 2010 Feb 15.


Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.

Park YH, Kim SU, Kwon TH, Kim JM, Song IS, Shin HJ, Lee BK, Bang DH, Lee SJ, Lee DS, Chang KT, Kim BY, Yu DY.

Oncogene. 2016 Jul 7;35(27):3503-13. doi: 10.1038/onc.2015.411. Epub 2015 Oct 26.


FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.


USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.

Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang W, Guan W, Zhou J, Wu Y, Qiu Y, Ding Y.

Oncol Rep. 2015 Aug;34(2):823-32. doi: 10.3892/or.2015.4065. Epub 2015 Jun 15.


Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.

Kopanja D, Pandey A, Kiefer M, Wang Z, Chandan N, Carr JR, Franks R, Yu DY, Guzman G, Maker A, Raychaudhuri P.

J Hepatol. 2015 Aug;63(2):429-36. doi: 10.1016/j.jhep.2015.03.023. Epub 2015 Mar 28.


The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.

Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC.

J Pathol. 2017 Dec;243(4):418-430. doi: 10.1002/path.4976. Epub 2017 Oct 27.


Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.

Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, De Miglio MR, Tomasi ML, Sanna V, Muroni MR, Feo F, Pascale RM.

Gut. 2009 May;58(5):679-87. doi: 10.1136/gut.2008.152652. Epub 2009 Jan 9.


LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.

Hu C, Liu D, Zhang Y, Lou G, Huang G, Chen B, Shen X, Gao M, Gong W, Zhou P, Dai S, Zeng Y, He F.

Oncogene. 2014 May 29;33(22):2888-97. doi: 10.1038/onc.2013.250. Epub 2013 Jul 1.


Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.

Weiler SME, Pinna F, Wolf T, Lutz T, Geldiyev A, Sticht C, Knaub M, Thomann S, Bissinger M, Wan S, Rössler S, Becker D, Gretz N, Lang H, Bergmann F, Ustiyan V, Kalin TV, Singer S, Lee JS, Marquardt JU, Schirmacher P, Kalinichenko VV, Breuhahn K.

Gastroenterology. 2017 Jun;152(8):2037-2051.e22. doi: 10.1053/j.gastro.2017.02.018. Epub 2017 Feb 27.


FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.

Shang R, Pu M, Li Y, Wang D.

Oncol Rep. 2017 Apr;37(4):2261-2269. doi: 10.3892/or.2017.5472. Epub 2017 Feb 22.


Down-regulation of FoxM1 inhibits viability and invasion of gallbladder carcinoma cells, partially dependent on inducement of cellular senescence.

Tao J, Xu XS, Song YZ, Qu K, Wu QF, Wang RT, Meng FD, Wei JC, Dong SB, Zhang YL, Tai MH, Dong YF, Wang L, Liu C.

World J Gastroenterol. 2014 Jul 28;20(28):9497-505. doi: 10.3748/wjg.v20.i28.9497.


Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma.

Li H, Fu X, Chen Y, Hong Y, Tan Y, Cao H, Wu M, Wang H.

Gastroenterology. 2005 Jun;128(7):2029-41.


Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.

Yu M, Tang Z, Meng F, Tai M, Zhang J, Wang R, Liu C, Wu Q.

Tumour Biol. 2016 Jan;37(1):1289-97. doi: 10.1007/s13277-015-3436-9. Epub 2015 Aug 20.


Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.

Huang W, Chen Z, Zhang L, Tian D, Wang D, Fan D, Wu K, Xia L.

Gastroenterology. 2015 Oct;149(4):1053-67.e14. doi: 10.1053/j.gastro.2015.05.058. Epub 2015 Jun 9.


FoxM1 influences mouse hepatocellular carcinoma metastasis in vitro.

Zhang N, Xie Y, Li B, Ning Z, Wang A, Cui X.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2771-8. eCollection 2015.

Supplemental Content

Support Center